Development of a TB vaccine trial site in Africa and lessons from the Ebola experience

Tuberculosis is the deadliest infection of our time. In contrast, about 11,000 people died of Ebola between 2014 and 2016. Despite this manifest difference in mortality, there is now a vaccine licensed in the United States and by the European Medicines Agency, with up to 100% efficacy against Ebola....

Descripción completa

Detalles Bibliográficos
Autores principales: Kaguthi, G., Nduba, V., Rabuogi, P., Okelloh, D., Ouma, S. G., Blatner, G., Gelderbloem, S., Mitchell, Ellen M. H., Scott, Cherise P., Verver, S., Hawkridge, T., de Steenwinkel, J. E. M., Laserson, K. F., Richardus, J. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316575/
https://www.ncbi.nlm.nih.gov/pubmed/32586316
http://dx.doi.org/10.1186/s12889-020-09051-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316575/
https://www.ncbi.nlm.nih.gov/pubmed/32586316
http://dx.doi.org/10.1186/s12889-020-09051-3

Ejemplares similares